Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pricing By Indication Takes Hold, Despite Hurdles

Jan 13 2017

• By Melanie Senior

IV1701_IndicationPricing_1200x675

Related Content

Drug Pricing: With "Value" Debate In Full Swing, ICER’s Influence Grows

Nov 02 2016

US Outcomes-Based Contracts: Big Uptick In Interest, But Not Execution

Nov 06 2016

Related Companies

Express Scripts Holding Company

Eli Lilly and Company

Memorial Sloan Kettering Cancer Center

AbbVie Inc.

Gilead Sciences, Inc.

CVS Health Corp.

Additional Topics

Market Access Pricing Strategies BioPharmaceutical

More from Market Access

More from In Vivo

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window